Statistics for Combination treatment with EGFR inhibitor and doxorubicin synergistically inhibits proliferation of MCF-7 cells and MDA-MB-231 triple-negative breast cancer cells In Vitro

Total visits

views
Combination treatment with EGFR inhibitor and doxorubicin synergistically inhibits proliferation of MCF-7 cells and MDA-MB-231 triple-negative breast cancer cells In Vitro 12

Total visits per month

views
January 2025 0
February 2025 0
March 2025 0
April 2025 0
May 2025 0
June 2025 0
July 2025 0

File Visits

views
Abrahams_Combination treatment with EGFR inhibitor_2024.pdf 124

Top country views

views
South Africa 12

Top city views

views
Bloemfontein 4
Johannesburg 2